Among the 7,831 unselective NSCLC tumors, our data showed that EGFR ex20ins mutations were detected in 129 patients, contributing 3.5% of all EGFR-mutation NSCLC and 1.6% of all NSCLC patients in China (Figure 2A). This evidence concerns the gene EGFR and non-small cell lung carcinoma.